ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
Holding ACAD?
Track your performance easily

ACADIA Pharmaceuticals (ACAD) Cash flow

2,254 Followers

ACADIA Pharmaceuticals Cash Flow

ACAD's free cash flow for Q3 2024 was $63.18M. For the 2024 fiscal year, ACAD's free cash flow was decreased by $90.69M and operating cash flow was $63.25M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 202.73M$ 16.70M$ -114.03M$ -125.66M$ -136.10M$ -151.10M
Investing Cash Flow
$ -153.03M$ 32.00M$ 73.24M$ -71.10M$ 192.51M$ -165.84M
Financing Cash Flow
$ 10.31M$ 25.13M$ 8.20M$ 18.16M$ 81.00M$ 371.85M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 751.76M$ 194.43M$ 120.62M$ 153.21M$ 331.87M$ 194.50M
Income Tax Paid Supplemental Data
$ 5.85M$ 5.85M$ 2.19M$ 1.04M$ 1.11M$ 1.60M
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 10.31M$ 25.13M$ 8.20M$ 18.16M$ 81.00M$ 371.85M
Issuance Of Debt
------
Repayment Of Debt
------
Free Cash Flow
$ 202.66M$ -23.35M$ -114.03M$ -126.78M$ -143.69M$ -152.22M
Domestic Sales
------
Foreign Sales
------
Currency in USD

ACADIA Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis